For millions grappling with the profound and persistent darkness of major depression, the journey to find an effective treatment can be a long and disheartening road, but a landmark clinical trial has now provided powerful evidence that an implanted medical device offers substantial and lasting
With over two decades of research in biopharma, Ivan Kairatov has witnessed the evolution of microbiome science from a niche interest into a central player in our understanding of health. As an expert in R&D and technological innovation, he has a unique perspective on the translational gap—the
A conservative West Virginia lawmaker and a progressive California governor rarely find common ground, yet they have become improbable allies in a sweeping national movement to fundamentally reshape what Americans eat and how public health is managed. This decentralized but powerful crusade,
With deep expertise in biopharmaceutical research and development, Ivan Kairatov has a front-row seat to the breakthroughs and setbacks that define modern medicine. He joins us to dissect the recent turbulence in the multiple sclerosis (MS) treatment landscape, where a promising new class of drugs
For the millions of people living with the relentless progression of Parkinson's disease, the daily battle for motor control has long been fought with a limited and often burdensome arsenal of treatments. The landscape of this fight is on the cusp of a dramatic transformation, however, as two
A recent international study is fundamentally changing the way clinicians understand and diagnose hereditary colorectal cancer, revealing that a direct analysis of colorectal polyp DNA can uncover critical information that standard blood tests frequently overlook. This groundbreaking research, a
